ArticlesHormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina
Introduction
Heterosexual transmission of HIV-1 is the predominant mode of infection among adults worldwide, while mother-to-child transmission accounts for most of the HIV-1 infection in children.1, 2 Of children who acquire HIV-1 from their mothers, 40–80% are estimated to become infected during delivery.2 For both heterosexual and mother-to-child transmission, factors that affect shedding of HIV-1 in cervical and vaginal secretions may be important determinants of transmission risk.
HIV-1 has been detected in cervical and vaginal secretions, as both the cell-associated and cell-free virus, by culture, PCR assays, and immunohistochemical techniques.3, 4, 5, 6, 7, 8 Correlates of HIV-1 shedding in the female genital tract have been addressed in only a few studies,4, 5, 6, 7 most of which have involved fewer than 100 women, and have had insufficient power to assess important potential correlates. Use of oral contraceptives, pregnancy, cervical ectopy, and cervical inflammation have been associated with detection of HIV-1 infected cells or free virus in some studies, but with conflicting results.4, 5, 6
John and co-workers'7 study of pregnant women infected with HIV-1 showed that genital-tract shedding of virus-infected cells was associated with CD4 depletion and abnormal cervical or vaginal discharge. The aim of our study was to assess whether use of oral and injectable hormonal contraceptives, immunosuppression, serum concentration of vitamin A, specific sexually transmitted diseases (STDs), and other variables were risk factors for cervical and vaginal shedding of HIV-1-infected cells.
Section snippets
Methods and patients
Between December, 1994, and April, 1996, we did a cross-sectional study of women who were seropositive for HIV-1 and attended a municipal STD clinic in Mombasa, Kenya. The clinic is a referral centre for women with symptoms of STDs and is also attended by prostitutes who receive regular government-mandated screening for STDs. Many of the women have been tested for HIV-1 antibodies in the context of another project at the clinic. Any woman not previously tested for HIV-1 was offered counselling
Microbiology and blood tests
We studied gram-stained vaginal secretions for bacterial vaginosis and scored them according to a ten-point system.9 We recorded the number of polymorphonuclear leucocytes in three non-adjacent, high-power fields of vaginal and cervical gram stains, and the presence of spermatozoa. Lactobacillus sp were cultured on Ragosa agar (Difco Laboratories, Detroit, MI, USA), and isolates were tested for production of hydrogen peroxide.10 We cultured T vaginalis in Diamonds modified medium (JRH
HIV-1 DNA detection
Cryovials that contained cervical and vaginal swabs were shipped to the University of Washington on dry ice and stored at −70°C. The samples were prepared and tested for HIV-1 DNA by nested PCR amplification of the gag gene, as described previously.7, 14 This assay is able to detect a single copy of HIV-1 DNA.14
Data analysis
Mann-Whitney U test, χ2 test, Fisher's exact test, and Spearman's correlation coefficient were used for initial univariate comparisons. Univariate tests of linear trend in the odds of HIV-1 DNA shedding with increasing or decreasing levels of exposure to HIV-1 were also done for selected variables.15 After univariate and stratified analyses, we used logistic regression to obtain adjusted estimates for key predictors—use of hormonal contraceptives, serum concentrations of vitamin A, and CD4
Results
We enrolled 318 women who were seropositive for HIV-1 (median age 28 [range 18–46] years; median number of sexual partners in the previous week 1 [0–6]). 223 (70%) women were prostitutes. There were no significant differences in mean number of sexual partners, condom use, or prevalence of STDs between prostitutes and the other women (data not shown). 182 (57%) women used no form of contraception at the time of assessment; 55 (17%) were using depot medroxyprogesterone acetate (DMPA); 25 (8%)
Endocervical shedding of HIV-1-infected cells
HIV-1 DNA was detected in 161 (51%) endocervical swabs from 315 women. Cervical swabs were unavailable from the three women who had had hysterectomies. Univariate correlates of cervical and vaginal shedding are shown in the table. Endocervical HIV-1 DNA was detected significantly more frequently in women who used oral contraceptives than in those who did not use hormonal contraceptives (78% vs 46%, p=0·0005). When stratified by non-users, use of low-dose oral contraceptives, and use of
Vaginal shedding of HIV-1 infected cells
HIV-1 DNA was detected in 44 (14%) vaginal swabs from 318 women. Vitamin A deficiency was highly associated with vaginal shedding of HIV-1 DNA; serum vitamin A concentrations less than 0·70 μmol/L, 0·70–1·04 μmol/L, 1·05–1·39 μmol/L, and 1·40 μmol/L or more were associated with 29%, 17%, 11%, and 2% prevalences of vaginal shedding, respectively (test for trend across four levels of exposure, p=0·00001). CD4 lymphocyte counts less than 200/μL, 200–499/μL, and 500/μL, or more were associated with
Discussion
The effects of hormonal contraceptives on cervical and vaginal shedding may reflect direct effects on the virus, effects on immune modulation of virus replication, or effects on local genital tract physiology. For example, steroid hormones have been shown to bind to the regulatory sequences of HIV-1 and upregulate expression of the virus.17, 18, 19 There is also growing evidence that endogenous oestrogens and progestins play a part in regulation of both hormonal and cell-mediated immunity.20, 21
References (36)
Global burden of the HIV pandemic
Lancet
(1996)- et al.
Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus
Lancet
(1986) - et al.
Serum estradiol in women ingesting combination oral contraceptive steroids
Am J Obstet Gynecol
(1972) - et al.
Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel
Am J Obsetet Gynecol
(1977) - et al.
Maternal vitamin A deficiency and mother-to-child transmission of HIV-1
Lancet
(1994) - et al.
Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers
Lancet
(1994) - et al.
Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial
Lancet
(1995) Epidemiology and determinants of vertical HIV transmission
Semin Pediatr Infect Dis
(1994)- et al.
Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women
J Acquir Immun Defic Syndr
(1993) - et al.
Detection of HIV DNA in cervical and vaginal secretions: prevalence and correlates among women in Nairobi, Kenya
JAMA
(1993)
Association between cervical inflammation and cervical shedding of HIV DNA
J Infect Dis
Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression and abnormal cervical or vaginal discharge, and severe vitamin A deficiency
J Infect Dis
Detection of HIV p17 antigen in lymphocytes but not epithelial cells from cervicovaginal secretions of women seropositive for HIV: implications for heterosexual transmission of the virus
Genitourin Med
Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation
J Clin Microbiol
Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis
J Clin Microbiol
A rapid manual method for CD4+ T- cell quantitation for use in developing countries
AIDS
Vitamin A deficiency: health, survival, and vision
Vitamin A, immunity, and infection
Clin Infect Dis
Cited by (269)
Safety of intrauterine devices among women with HIV: a systematic review
2016, ContraceptionCitation Excerpt :Landolt found that among 29 women with HIV using copper IUDs, there were no significant changes in CD4 count or HIV RNA at 6 months of follow up [18]. Six articles addressed HIV transmission, including one article that provided direct evidence on transmission from women with HIV to noninfected male partners [20] and five articles that provided indirect evidence on surrogate markers of infectivity such as genital viral shedding (Table 3) [8,11,15,21,22]. Plasma viral load may also be a surrogate marker of infectivity; however, changes in viral load are discussed above as part of key Question 2 on HIV disease progression.
Immunology of the Female Reproductive Mucosa
2016, Encyclopedia of ImmunobiologyHIV and Men
2016, Sexual Medicine ReviewsHuman Immunodeficiency Virus Infection in Women
2014, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases